• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD28共刺激对HIV阳性患者的抗病毒作用及体外CD4 + T细胞增殖的影响

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.

作者信息

Levine B L, Mosca J D, Riley J L, Carroll R G, Vahey M T, Jagodzinski L L, Wagner K F, Mayers D L, Burke D S, Weislow O S, St Louis D C, June C H

机构信息

Naval Medical Research Institute, Bethesda, Maryland 20889, USA.

出版信息

Science. 1996 Jun 28;272(5270):1939-43. doi: 10.1126/science.272.5270.1939.

DOI:10.1126/science.272.5270.1939
PMID:8658167
Abstract

Because stimulation of CD4+ lymphocytes leads to activation of human immunodeficiency virus-type 1 (HIV-1) replication, viral spread, and cell death, adoptive CD4+ T cell therapy has not been possible. When antigen and CD28 receptors on cultured T cells were stimulated by monoclonal antibodies (mAbs) to CD3 and CD28 that had been immobilized, there was an increase in the number of polyclonal CD4+ T cells from HIV-infected donors. Activated cells predominantly secreted cytokines associated with T helper cell type 1 function. The HIV-1 viral load declined in the absence of antiretroviral agents. Moreover, CD28 stimulation of CD4+ T cells from uninfected donors rendered these cells highly resistant to HIV-1 infection. Immobilization of CD28 mAb was crucial to the development of HIV resistance, as cells stimulated with soluble CD28 mAb were highly susceptible to HIV infection. The CD28-mediated antiviral effect occurred early in the viral life cycle, before HIV-1 DNA integration. These data may facilitate immune reconstitution and gene therapy approaches in persons with HIV infection.

摘要

由于刺激CD4 +淋巴细胞会导致1型人类免疫缺陷病毒(HIV-1)复制、病毒传播和细胞死亡,因此过继性CD4 + T细胞疗法一直无法实现。当通过固定化的抗CD3和抗CD28单克隆抗体(mAb)刺激培养的T细胞上的抗原和CD28受体时,来自HIV感染供体的多克隆CD4 + T细胞数量增加。活化细胞主要分泌与1型辅助性T细胞功能相关的细胞因子。在没有抗逆转录病毒药物的情况下,HIV-1病毒载量下降。此外,用未感染供体的CD抗原刺激CD4 + T细胞可使这些细胞对HIV-1感染具有高度抗性。固定化CD28单克隆抗体对于HIV抗性的发展至关重要,因为用可溶性CD28单克隆抗体刺激的细胞对HIV感染高度敏感。CD28介导的抗病毒作用发生在病毒生命周期的早期,在HIV-1 DNA整合之前。这些数据可能有助于HIV感染者的免疫重建和基因治疗方法。

相似文献

1
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.CD28共刺激对HIV阳性患者的抗病毒作用及体外CD4 + T细胞增殖的影响
Science. 1996 Jun 28;272(5270):1939-43. doi: 10.1126/science.272.5270.1939.
2
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.CD28共刺激CD4 + T细胞对HIV-1融合辅助因子表达的差异调节。
Science. 1997 Apr 11;276(5310):273-6. doi: 10.1126/science.276.5310.273.
3
The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro.抗CD28共刺激的方式和持续时间决定了体外对人免疫缺陷病毒1型巨噬细胞嗜性毒株感染的抵抗力。
J Virol. 1999 Nov;73(11):9337-47. doi: 10.1128/JVI.73.11.9337-9347.1999.
4
Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.对CD3加CD28单克隆抗体的低T细胞反应可预测艾滋病的发展。
AIDS. 1998 Oct 1;12(14):1745-51. doi: 10.1097/00002030-199814000-00005.
5
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.CD32 表达与 T 细胞激活相关,而不是 HIV-1 储存库的标志物。
Nat Commun. 2018 Jul 16;9(1):2739. doi: 10.1038/s41467-018-05157-w.
6
Development of an animal model for autotransfusion therapy: in vitro characterization and analysis of anti-CD3/CD28 expanded cells.自体输血治疗动物模型的建立:抗CD3/CD28扩增细胞的体外特性鉴定与分析
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):210-20. doi: 10.1097/00042560-199811010-00002.
7
Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.Toll样受体2连接通过增加病毒进入并建立更易感染的环境来增强HIV-1在活化的CCR6 + CD4 + T细胞中的复制。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01402-16. Print 2017 Feb 15.
8
Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.抑制CD3/CD28介导的MEK/ERK信号通路激活可抑制X4型而非R5型人类免疫缺陷病毒1型在外周血CD4(+) T淋巴细胞中的复制。
J Virol. 2000 Mar;74(6):2558-66. doi: 10.1128/jvi.74.6.2558-2566.2000.
9
A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.肿瘤坏死因子-α在调节人类和非人类灵长类动物活化的CD4+ T细胞对使用慢病毒的不同共受体的易感性方面的新作用。
J Acquir Immune Defic Syndr. 2000 May 1;24(1):10-22. doi: 10.1097/00126334-200005010-00003.
10
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.CD28的激活可调节静息和CD3刺激的CD4 + T细胞中CXC趋化因子受体4的表面表达。
J Immunol. 2000 Apr 15;164(8):4018-24. doi: 10.4049/jimmunol.164.8.4018.

引用本文的文献

1
Engineering mRNA CAR-T Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化信使核糖核酸嵌合抗原受体T细胞
Methods Mol Biol. 2025;2965:285-321. doi: 10.1007/978-1-0716-4742-4_14.
2
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy.嵌合抗原受体工程化细胞免疫疗法的当前挑战与新出现的机遇
Exp Hematol Oncol. 2025 Jul 2;14(1):92. doi: 10.1186/s40164-025-00683-y.
3
From concept to cure: The evolution of CAR-T cell therapy.从概念到治愈:嵌合抗原受体T细胞疗法的演变
Mol Ther. 2025 May 7;33(5):2123-2140. doi: 10.1016/j.ymthe.2025.03.005. Epub 2025 Mar 10.
4
Immunomodulatory activity of heat-killed MCC1849 based on the activation of plasmacytoid dendritic cells in the peripheral blood of healthy adults.基于健康成年人外周血中浆细胞样树突状细胞的激活,热灭活的MCC1849的免疫调节活性。
Food Sci Nutr. 2024 Feb 7;12(5):3452-3460. doi: 10.1002/fsn3.4009. eCollection 2024 May.
5
The Expression of LDL-R in CD8 T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells.CD8 T 细胞中 LDL-R 的表达可作为 TCR-T 细胞产生的早期评估参数。
In Vivo. 2023 Nov-Dec;37(6):2480-2489. doi: 10.21873/invivo.13355.
6
CAR T therapy beyond cancer: the evolution of a living drug.CAR T 疗法超越癌症:活药物的演变。
Nature. 2023 Jul;619(7971):707-715. doi: 10.1038/s41586-023-06243-w. Epub 2023 Jul 26.
7
Biphasic response of T cell activation to substrate stiffness.T 细胞激活对基质硬度的双相反应。
Biomaterials. 2021 Jun;273:120797. doi: 10.1016/j.biomaterials.2021.120797. Epub 2021 Apr 12.
8
Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.采用过继性 T 细胞疗法作为 HIV 治愈策略的一部分所面临的挑战与机遇。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):38-45. doi: 10.1093/infdis/jiaa223.
9
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.经过编辑的 CCR5 基因修饰的 CD4+ T 细胞增强了 HIV 特异性免疫,从而实现了 HIV 复制后反弹的控制。
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI144486.
10
Suppressive activity of Vδ2 γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength.Vδ2 γδ T 细胞对 αβ T 细胞的抑制活性受 TCR 信号的许可,并与信号强度相关。
Cancer Immunol Immunother. 2020 Apr;69(4):593-610. doi: 10.1007/s00262-019-02469-8. Epub 2020 Jan 25.